SMO Clinplus Co (SZSE:301257) Total Stockholders Equity : ¥1,106.2 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co Total Stockholders Equity?

SMO Clinplus Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,106.2 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. SMO Clinplus Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥13.91. The ratio of a company's debt over equity can be used to measure how leveraged this company is. SMO Clinplus Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.01.

SMO Clinplus Co Total Stockholders Equity Historical Data

The historical data trend for SMO Clinplus Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co Total Stockholders Equity Chart

SMO Clinplus Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

125.19

164.96

228.84

951.97

1,080.60

SMO Clinplus Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															981.01	998.12	1,041.28	1,080.60	1,106.22

SMO Clinplus Co (SZSE:301257) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

SMO Clinplus Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1106.217	-	0)	/	79.508
	=	13.91

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

SMO Clinplus Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.856	+	3.229)	/	1106.217
	=	0.01

SMO Clinplus Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of SMO Clinplus Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SMO Clinplus Co (SZSE:301257) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001

Website

http://www.smo-clinplus.com

SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.

Executives

Lai Chun Bao	Director
Ma Lin	Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines